753 related articles for article (PubMed ID: 18054933)
1. Systemic methotrexate to treat ectopic pregnancy does not affect ovarian reserve.
Oriol B; Barrio A; Pacheco A; Serna J; Zuzuarregui JL; Garcia-Velasco JA
Fertil Steril; 2008 Nov; 90(5):1579-82. PubMed ID: 18054933
[TBL] [Abstract][Full Text] [Related]
2. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.
Wunder DM; Guibourdenche J; Birkhäuser MH; Bersinger NA
Fertil Steril; 2008 Dec; 90(6):2203-10. PubMed ID: 18291376
[TBL] [Abstract][Full Text] [Related]
3. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
Elgindy EA; El-Haieg DO; El-Sebaey A
Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
[TBL] [Abstract][Full Text] [Related]
4. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial.
Serna J; Cholquevilque JL; Cela V; Martínez-Salazar J; Requena A; Garcia-Velasco JA
Fertil Steril; 2008 Dec; 90(6):2190-5. PubMed ID: 18191847
[TBL] [Abstract][Full Text] [Related]
5. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
[TBL] [Abstract][Full Text] [Related]
6. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
[TBL] [Abstract][Full Text] [Related]
7. Does methotrexate administration for ectopic pregnancy after in vitro fertilization impact ovarian reserve or ovarian responsiveness?
Boots CE; Gustofson RL; Feinberg EC
Fertil Steril; 2013 Dec; 100(6):1590-3. PubMed ID: 24035728
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate does not affect ovarian reserve or subsequent assisted reproductive technology outcomes.
Boots CE; Hill MJ; Feinberg EC; Lathi RB; Fowler SA; Jungheim ES
J Assist Reprod Genet; 2016 May; 33(5):647-656. PubMed ID: 26943917
[TBL] [Abstract][Full Text] [Related]
9. Oocyte quality in patients with severe ovarian hyperstimulation syndrome: a self-controlled clinical study.
Fábregues F; Peñarrubia J; Vidal E; Casals G; Vanrell JA; Balasch J
Fertil Steril; 2004 Oct; 82(4):827-33. PubMed ID: 15482755
[TBL] [Abstract][Full Text] [Related]
10. Does methotrexate treatment for ectopic pregnancy influence the patient's performance during a subsequent in vitro fertilization/embryo transfer cycle?
Orvieto R; Kruchkovich J; Zohav E; Rabinson J; Anteby EY; Meltcer S
Fertil Steril; 2007 Dec; 88(6):1685-6. PubMed ID: 17493622
[TBL] [Abstract][Full Text] [Related]
11. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
[TBL] [Abstract][Full Text] [Related]
12. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
[TBL] [Abstract][Full Text] [Related]
13. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
Majumder K; Gelbaya TA; Laing I; Nardo LG
Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
[TBL] [Abstract][Full Text] [Related]
14. Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome.
Mashiach R; Amit A; Hasson J; Amzalzg S; Almog B; Ben-Yosef D; Lessing JB; Limor R; Azem F
Fertil Steril; 2010 May; 93(7):2299-302. PubMed ID: 19261276
[TBL] [Abstract][Full Text] [Related]
15. Anti-Müllerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in vitro fertilization.
Takahashi C; Fujito A; Kazuka M; Sugiyama R; Ito H; Isaka K
Fertil Steril; 2008 Mar; 89(3):586-91. PubMed ID: 17543956
[TBL] [Abstract][Full Text] [Related]
16. What is the best time to perform intracytoplasmic sperm injection/embryo transfer cycle after hysteroscopic surgery for an incomplete uterine septum?
Berkkanoglu M; Isikoglu M; Arici F; Ozgur K
Fertil Steril; 2008 Dec; 90(6):2112-5. PubMed ID: 18177864
[TBL] [Abstract][Full Text] [Related]
17. Correlations between anti-müllerian hormone, inhibin B, and activin A in follicular fluid in IVF/ICSI patients for assessing the maturation and developmental potential of oocytes.
Cupisti S; Dittrich R; Mueller A; Strick R; Stiegler E; Binder H; Beckmann MW; Strissel P
Eur J Med Res; 2007 Dec; 12(12):604-8. PubMed ID: 18024272
[TBL] [Abstract][Full Text] [Related]
18. Effects of polycystic ovarian syndrome on in vitro fertilization-embryo transfer outcomes are influenced by body mass index.
McCormick B; Thomas M; Maxwell R; Williams D; Aubuchon M
Fertil Steril; 2008 Dec; 90(6):2304-9. PubMed ID: 18191852
[TBL] [Abstract][Full Text] [Related]
19. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
20. Reproductive outcome after methotrexate treatment of tubal pregnancies.
Gervaise A; Masson L; de Tayrac R; Frydman R; Fernandez H
Fertil Steril; 2004 Aug; 82(2):304-8. PubMed ID: 15302275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]